Hydrogen Sulfide Prevents Advanced Glycation End-Products Induced Activation of the Epithelial Sodium Channel
Advanced glycation end-products (AGEs) are complex and heterogeneous compounds implicated in diabetes. Sodium reabsorption through the epithelial sodium channel (ENaC) at the distal nephron plays an important role in diabetic hypertension. Here, we report that H2S antagonizes AGEs-induced ENaC activ...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2015-01-01
|
Series: | Oxidative Medicine and Cellular Longevity |
Online Access: | http://dx.doi.org/10.1155/2015/976848 |
id |
doaj-77aa8757063946d18c886e792c863021 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Qiushi Wang Binlin Song Shuai Jiang Chen Liang Xiao Chen Jing Shi Xinyuan Li Yingying Sun Mingming Wu Dan Zhao Zhi-Ren Zhang He-Ping Ma |
spellingShingle |
Qiushi Wang Binlin Song Shuai Jiang Chen Liang Xiao Chen Jing Shi Xinyuan Li Yingying Sun Mingming Wu Dan Zhao Zhi-Ren Zhang He-Ping Ma Hydrogen Sulfide Prevents Advanced Glycation End-Products Induced Activation of the Epithelial Sodium Channel Oxidative Medicine and Cellular Longevity |
author_facet |
Qiushi Wang Binlin Song Shuai Jiang Chen Liang Xiao Chen Jing Shi Xinyuan Li Yingying Sun Mingming Wu Dan Zhao Zhi-Ren Zhang He-Ping Ma |
author_sort |
Qiushi Wang |
title |
Hydrogen Sulfide Prevents Advanced Glycation End-Products Induced Activation of the Epithelial Sodium Channel |
title_short |
Hydrogen Sulfide Prevents Advanced Glycation End-Products Induced Activation of the Epithelial Sodium Channel |
title_full |
Hydrogen Sulfide Prevents Advanced Glycation End-Products Induced Activation of the Epithelial Sodium Channel |
title_fullStr |
Hydrogen Sulfide Prevents Advanced Glycation End-Products Induced Activation of the Epithelial Sodium Channel |
title_full_unstemmed |
Hydrogen Sulfide Prevents Advanced Glycation End-Products Induced Activation of the Epithelial Sodium Channel |
title_sort |
hydrogen sulfide prevents advanced glycation end-products induced activation of the epithelial sodium channel |
publisher |
Hindawi Limited |
series |
Oxidative Medicine and Cellular Longevity |
issn |
1942-0900 1942-0994 |
publishDate |
2015-01-01 |
description |
Advanced glycation end-products (AGEs) are complex and heterogeneous compounds implicated in diabetes. Sodium reabsorption through the epithelial sodium channel (ENaC) at the distal nephron plays an important role in diabetic hypertension. Here, we report that H2S antagonizes AGEs-induced ENaC activation in A6 cells. ENaC open probability (PO) in A6 cells was significantly increased by exogenous AGEs and that this AGEs-induced ENaC activity was abolished by NaHS (a donor of H2S) and TEMPOL. Incubating A6 cells with the catalase inhibitor 3-aminotriazole (3-AT) mimicked the effects of AGEs on ENaC activity, but did not induce any additive effect. We found that the expression levels of catalase were significantly reduced by AGEs and both AGEs and 3-AT facilitated ROS uptake in A6 cells, which were significantly inhibited by NaHS. The specific PTEN and PI3K inhibitors, BPV(pic) and LY294002, influence ENaC activity in AGEs-pretreated A6 cells. Moreover, after removal of AGEs from AGEs-pretreated A6 cells for 72 hours, ENaC PO remained at a high level, suggesting that an AGEs-related “metabolic memory” may be involved in sodium homeostasis. Our data, for the first time, show that H2S prevents AGEs-induced ENaC activation by targeting the ROS/PI3K/PTEN pathway. |
url |
http://dx.doi.org/10.1155/2015/976848 |
work_keys_str_mv |
AT qiushiwang hydrogensulfidepreventsadvancedglycationendproductsinducedactivationoftheepithelialsodiumchannel AT binlinsong hydrogensulfidepreventsadvancedglycationendproductsinducedactivationoftheepithelialsodiumchannel AT shuaijiang hydrogensulfidepreventsadvancedglycationendproductsinducedactivationoftheepithelialsodiumchannel AT chenliang hydrogensulfidepreventsadvancedglycationendproductsinducedactivationoftheepithelialsodiumchannel AT xiaochen hydrogensulfidepreventsadvancedglycationendproductsinducedactivationoftheepithelialsodiumchannel AT jingshi hydrogensulfidepreventsadvancedglycationendproductsinducedactivationoftheepithelialsodiumchannel AT xinyuanli hydrogensulfidepreventsadvancedglycationendproductsinducedactivationoftheepithelialsodiumchannel AT yingyingsun hydrogensulfidepreventsadvancedglycationendproductsinducedactivationoftheepithelialsodiumchannel AT mingmingwu hydrogensulfidepreventsadvancedglycationendproductsinducedactivationoftheepithelialsodiumchannel AT danzhao hydrogensulfidepreventsadvancedglycationendproductsinducedactivationoftheepithelialsodiumchannel AT zhirenzhang hydrogensulfidepreventsadvancedglycationendproductsinducedactivationoftheepithelialsodiumchannel AT hepingma hydrogensulfidepreventsadvancedglycationendproductsinducedactivationoftheepithelialsodiumchannel |
_version_ |
1725794824623226880 |
spelling |
doaj-77aa8757063946d18c886e792c8630212020-11-24T22:15:21ZengHindawi LimitedOxidative Medicine and Cellular Longevity1942-09001942-09942015-01-01201510.1155/2015/976848976848Hydrogen Sulfide Prevents Advanced Glycation End-Products Induced Activation of the Epithelial Sodium ChannelQiushi Wang0Binlin Song1Shuai Jiang2Chen Liang3Xiao Chen4Jing Shi5Xinyuan Li6Yingying Sun7Mingming Wu8Dan Zhao9Zhi-Ren Zhang10He-Ping Ma11Departments of Clinical Pharmacy and Cardiology, Institute of Clinical Pharmacy, The Second Affiliated Hospital, Harbin Medical University, Key Laboratories of Education Ministry for Myocardial Ischemia Mechanism and Treatment, Harbin 150086, ChinaDepartments of Clinical Pharmacy and Cardiology, Institute of Clinical Pharmacy, The Second Affiliated Hospital, Harbin Medical University, Key Laboratories of Education Ministry for Myocardial Ischemia Mechanism and Treatment, Harbin 150086, ChinaDepartments of Clinical Pharmacy and Cardiology, Institute of Clinical Pharmacy, The Second Affiliated Hospital, Harbin Medical University, Key Laboratories of Education Ministry for Myocardial Ischemia Mechanism and Treatment, Harbin 150086, ChinaDepartments of Clinical Pharmacy and Cardiology, Institute of Clinical Pharmacy, The Second Affiliated Hospital, Harbin Medical University, Key Laboratories of Education Ministry for Myocardial Ischemia Mechanism and Treatment, Harbin 150086, ChinaDepartments of Clinical Pharmacy and Cardiology, Institute of Clinical Pharmacy, The Second Affiliated Hospital, Harbin Medical University, Key Laboratories of Education Ministry for Myocardial Ischemia Mechanism and Treatment, Harbin 150086, ChinaDepartments of Clinical Pharmacy and Cardiology, Institute of Clinical Pharmacy, The Second Affiliated Hospital, Harbin Medical University, Key Laboratories of Education Ministry for Myocardial Ischemia Mechanism and Treatment, Harbin 150086, ChinaDepartments of Clinical Pharmacy and Cardiology, Institute of Clinical Pharmacy, The Second Affiliated Hospital, Harbin Medical University, Key Laboratories of Education Ministry for Myocardial Ischemia Mechanism and Treatment, Harbin 150086, ChinaDepartments of Clinical Pharmacy and Cardiology, Institute of Clinical Pharmacy, The Second Affiliated Hospital, Harbin Medical University, Key Laboratories of Education Ministry for Myocardial Ischemia Mechanism and Treatment, Harbin 150086, ChinaDepartments of Clinical Pharmacy and Cardiology, Institute of Clinical Pharmacy, The Second Affiliated Hospital, Harbin Medical University, Key Laboratories of Education Ministry for Myocardial Ischemia Mechanism and Treatment, Harbin 150086, ChinaDepartments of Clinical Pharmacy and Cardiology, Institute of Clinical Pharmacy, The Second Affiliated Hospital, Harbin Medical University, Key Laboratories of Education Ministry for Myocardial Ischemia Mechanism and Treatment, Harbin 150086, ChinaDepartments of Clinical Pharmacy and Cardiology, Institute of Clinical Pharmacy, The Second Affiliated Hospital, Harbin Medical University, Key Laboratories of Education Ministry for Myocardial Ischemia Mechanism and Treatment, Harbin 150086, ChinaDepartment of Physiology, Emory University School of Medicine, Atlanta, GA 30322, USAAdvanced glycation end-products (AGEs) are complex and heterogeneous compounds implicated in diabetes. Sodium reabsorption through the epithelial sodium channel (ENaC) at the distal nephron plays an important role in diabetic hypertension. Here, we report that H2S antagonizes AGEs-induced ENaC activation in A6 cells. ENaC open probability (PO) in A6 cells was significantly increased by exogenous AGEs and that this AGEs-induced ENaC activity was abolished by NaHS (a donor of H2S) and TEMPOL. Incubating A6 cells with the catalase inhibitor 3-aminotriazole (3-AT) mimicked the effects of AGEs on ENaC activity, but did not induce any additive effect. We found that the expression levels of catalase were significantly reduced by AGEs and both AGEs and 3-AT facilitated ROS uptake in A6 cells, which were significantly inhibited by NaHS. The specific PTEN and PI3K inhibitors, BPV(pic) and LY294002, influence ENaC activity in AGEs-pretreated A6 cells. Moreover, after removal of AGEs from AGEs-pretreated A6 cells for 72 hours, ENaC PO remained at a high level, suggesting that an AGEs-related “metabolic memory” may be involved in sodium homeostasis. Our data, for the first time, show that H2S prevents AGEs-induced ENaC activation by targeting the ROS/PI3K/PTEN pathway.http://dx.doi.org/10.1155/2015/976848 |